Pat Davis, CEO, InsurePay.
Davis brings experience in insurance technology and InsurTech, having previously founded and led Utilant (Buffalo, N.Y.), a provider of survey management software for property/casualty carriers. Under his leadership, Utilant expanded into a global enterprise serving major insurers across multiple markets.
At InsurePay, Davis will focus on enhancing the company’s payments platform and advancing its Pay-As-You-Go (PayGo) billing capabilities. The platform uses AI and connected data to improve premium calculations, underwriting, and audits for carriers, agents, and policyholders.
“I am thrilled to join InsurePay at this exciting time in the company’s journey,” says Davis. “InsurePay has built a strong foundation in insurance payments and PayGo solutions, and I look forward to expanding the platform to deliver greater efficiency, accuracy, and value for our customers.”
Joe Maxwell, Managing Partner, FinTop Capital.
The appointment follows investment support from FinTop Capital and Aquiline, reflecting continued investor confidence in InsurePay’s strategy.
Track Record of Building and Scaling Transformative Businesses
“Pat is an exceptional leader with a proven track record of building and scaling transformative fintech businesses,” comments Joe Maxwell, managing partner, FinTop Capital. “His vision and operational expertise will accelerate InsurePay’s mission to modernize insurance payments and advance PayGo solutions that deliver real-time accuracy and value.”
Dante La Ruffa, Partner, Aquiline.
Dante La Ruffa, partner at Aquiline, adds: “We’re excited to welcome Pat to InsurePay. His entrepreneurial background and customer-first mindset align well with the company’s strategy. As carriers show growing interest in flexible billing solutions, InsurePay is well positioned to lead.”
InsurePay offers digital billing and payment solutions to insurance carriers, agents, and policyholders. Its platform supports PayGo billing, payment reconciliation, and real-time data integration to enhance billing accuracy and operational efficiency.
Utilant Gets ‘Significant’ Capital Infusion from Aquiline Technology Growth